Placebo to BI 1060469
Sponsors
Boehringer Ingelheim
Conditions
AsthmaHealthy
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469
CompletedNCT01971502
Start: 2013-10-31End: 2014-02-28Updated: 2014-10-27
Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients
CompletedNCT02126865
Start: 2014-05-31End: 2015-07-31Updated: 2015-08-14